Literature DB >> 27267298

Inhalation devices: from basic science to practical use, innovative vs generic products.

Michal Pirozynski1, Tomasz R Sosnowski2.   

Abstract

INTRODUCTION: Inhalation therapy is a convenient method of treating respiratory diseases. The key factors required for inhalation are the preparation of drug carriers (aerosol particles) allowing reproducible dosing during administration. These technical challenges are accomplished with a variety of inhalation devices (inhalers) and medicinal formulations, which are optimized to be easily converted into inhalable aerosols. Areas covered: This review is focused on the most important, but often overlooked, effects, which are required for the reliable and reproducible inhalable drug administration. The effects of patient-related issues that influence inhalation therapy, such as proper selection of inhalers for specific cases is discussed. We also discuss factors that are the most essential if generic inhalation product should be considered equivalent to the drugs with the clinically confirmed efficacy. Expert opinion: Proper device selection is crucial in clinical results of inhalation therapy. The patients' ability to coordinate inhalation with actuation, generation of optimal flow through the device, use of optimal inspiratory volume, all produces crucial effects on disease control. Also the severity of the disease process effects proper use of inhalers. Interchanging of inhalers can produce potentially conflicting problem regarding efficacy and safety of inhalation therapy.

Entities:  

Keywords:  Drug administration; aerosol; bioequivalence; drug approval; drug delivery systems; generic drugs; inhalation; inhalers; lung deposition; nebulizers and vaporizers

Mesh:

Substances:

Year:  2016        PMID: 27267298     DOI: 10.1080/17425247.2016.1198774

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  8 in total

1.  Preclinical Development of Orally Inhaled Drugs (OIDs)-Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?

Authors:  Dania Movia; Adriele Prina-Mello
Journal:  Animals (Basel)       Date:  2020-07-24       Impact factor: 2.752

2.  Analysis of the Consumption of Drugs Prescribed for the Treatment of Asthma in Belgian Children.

Authors:  Natacha Biset; Wies Kestens; Dominique Detemmerman; Murielle Lona; Güngör Karakaya; Ann Ceuppens; Stéphanie Pochet; Carine De Vriese
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

3.  Aqueous dispersions of oxygen nanobubbles for potential application in inhalation therapy.

Authors:  Marcin Odziomek; Karol Ulatowski; Katarzyna Dobrowolska; Izabela Górniak; Paweł Sobieszuk; Tomasz R Sosnowski
Journal:  Sci Rep       Date:  2022-07-21       Impact factor: 4.996

4.  Efficacy and usability of a novel nebulizer targeting both upper and lower airways.

Authors:  Daniela Posa; Antonio Pizzulli; Petra Wagner; Serena Perna; Stephanie Hofmaier; Paolo Maria Matricardi; Susanne Lau
Journal:  Ital J Pediatr       Date:  2017-09-29       Impact factor: 2.638

5.  Objective Assessment of Patient Inhaler User Technique Using an Audio-Based Classification Approach.

Authors:  Terence E Taylor; Yaniv Zigel; Clarice Egan; Fintan Hughes; Richard W Costello; Richard B Reilly
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

6.  The impact of nasal aspiration with an automatic device on upper and lower respiratory symptoms in wheezing children: a pilot case-control study.

Authors:  Antonio Pizzulli; Serena Perna; Anja Bennewiz; Holger Roeblitz; Salvatore Tripodi; Jakob Florack; Petra Wagner; Stephanie Hofmaier; Paolo Maria Matricardi
Journal:  Ital J Pediatr       Date:  2018-06-14       Impact factor: 2.638

Review 7.  Particle Size Dynamics: Toward a Better Understanding of Electronic Cigarette Aerosol Interactions With the Respiratory System.

Authors:  Tomasz R Sosnowski; Marcin Odziomek
Journal:  Front Physiol       Date:  2018-07-09       Impact factor: 4.566

8.  Aerosol Characteristics and Physico-Chemical Compatibility of Combivent® (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine.

Authors:  Rui Zhang; Junhua Hu; Liangjun Deng; Sha Li; Xi Chen; Fei Liu; Shanping Wang; Khaja Shameem Mohammed Abdul; Huimin Beng; Wen Tan
Journal:  Pharmaceutics       Date:  2020-01-17       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.